DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

会议日程

天 1 2017 年 10 月 25 日

8:00 AM — 8:30 AM

Welcome Remarks and Overview of the 2017 Conference

8:30 AM — 10:30 AM

Session 1: The Emerging Landscape of mRNA-Based Drugs: A New Modality in Vaccines and Therapeutics

天 2 2017 年 10 月 26 日

8:15 AM — 9:00 AM

9:00 AM — 9:05 AM

Welcome to Day Two

9:05 AM — 10:05 AM

Session 5: Keynote Address

12:00 PM — 1:15 PM

Japanese Perspective on the Preclinical Safety Assessment of Oligonucleotide Therapeutics

3:30 PM — 5:00 PM

Session 8: Gene Editing: Driving CRISPR to the Clinic in Different Vehicles

5:00 PM — 5:30 PM

DIA Oligonucleotide Safety Working Group (OSWG) – Open Meeting

天 3 2017 年 10 月 27 日

9:45 AM — 11:15 AM

Session 10: Hot Topics in Oligonucleotide Therapeutics

11:15 AM — 12:00 PM

Closing Session: Panel Discussion